Company SinoMab BioScience Limited

3681

HK0000544194

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Biopharmaceuticals

Delayed Hong Kong S.E. Other stock markets 06:44:25 07/05/2024 BST			5-day change	1st Jan Change
1.87 ^HKD	+1.08%		-1.60%	+10.12%

03-25	SinoMab BioScience Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-07	SinoMab BioScience Limited Appoints Shanchun Wang as an Executive Director	CI

SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Companyâs product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE), asthma, pemphigus, sjogrenâs syndrome (SS) and other immunological diseases.

Number of employees: 215

Managers	Title	Age	Since
Shui On Leung CEO	Chief Executive Officer	64	26/04/01
Jian Ping Hua DFI	Director of Finance/CFO	42	31/12/18
Li Xin Zhang CTO	Chief Tech/Sci/R&D Officer	60	31/07/21
Shan Chun Wang BRD	Director/Board Member	56	31/12/21
Ka Wa Benny Cheung PRN	Corporate Officer/Principal	44	31/12/09
Kwan Yin Siu PRN	Corporate Officer/Principal	45	-
Ming Hon Yau PRN	Corporate Officer/Principal	45	31/12/11
Yuk Yin Chow SEC	Corporate Secretary	53	30/03/23

Members of the board	Title	Age	Since
Dylan Tinker BRD	Director/Board Member	55	30/10/19
Ping Cho Hon BRD	Director/Board Member	64	30/10/19
Hai Gang Chen BRD	Director/Board Member	41	31/07/17
Chi Ming Lee BRD	Director/Board Member	70	14/06/21
Wenyi Liu BRD	Director/Board Member	37	31/07/17
Shui On Leung CEO	Chief Executive Officer	64	26/04/01
George William Hunter Cautherley BRD	Director/Board Member	81	22/12/19
Xun Dong BRD	Director/Board Member	50	22/12/19
Lei Shi BRD	Director/Board Member	38	16/12/21
Jian Min Zhang BRD	Director/Board Member	46	05/09/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,091,755,119	412,298,663 ( 37.76 %)	0	37.76 %

Name	Equities	%	Valuation
Shanghai Xingze Investment Management Co. Ltd. 16.55 %	180,665,600	16.55 %	36 M $
CHINA CITIC BANK CORPORATION LIMITED 14.55 %	158,882,115	14.55 %	32 M $
Shui On Leung 11.88 %	129,729,200	11.88 %	26 M $
Si Jia Xu 8.225 %	89,802,105	8.225 %	18 M $
Jing Qiang 6.670 %	72,823,636	6.670 %	15 M $
YUNNAN BAIYAO GROUP CO.,LTD 4.613 %	50,357,700	4.613 %	10 M $
Shan Chun Wang 3.248 %	35,464,800	3.248 %	7 M $
Wenyi Liu 1.825 %	19,923,000	1.825 %	4 M $

Sinomab Bioscience Ltd.

Hong Kong Science Park, Pak Shek Kok No.15 Science Park West Avenue

, Hong Kong

http://www.sinomab.com

address SinoMab BioScience Limited(3681)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
SINOMAB BIOSCIENCE LIMITED	+10.12%	258M
CSL LIMITED	-2.56%	88.14B
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.44B
BIOGEN INC.	-14.43%	32.24B
UCB	+51.20%	24.39B
BIOMARIN PHARMACEUTICAL INC.	-14.85%	15.59B
INCYTE CORPORATION	-13.87%	12.14B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-7.87%	12.18B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-39.40%	12.3B
SWEDISH ORPHAN BIOVITRUM AB	+5.62%	8.87B

Biopharmaceuticals